 Cyclosporine treatment cutaneous cell lymphoma present observations use cyclosporine treatment patients mycosis fungoides patients Sezary syndrome patients mycosis fungoides mild improvement short duration patient Sezary syndrome significant improvement years treatment unlikely sufficient therapy cutaneous cell lymphoma doses conjunction immunomodulators potential side effects lead lasting clinical improvement